rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib.
|
23676790 |
2013 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinib.
|
21489624 |
2011 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
|
21562040 |
2011 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.
|
21562040 |
2011 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia.
|
21895409 |
2011 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: is that true for all the patients?
|
21605905 |
2011 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinib.
|
21489624 |
2011 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
Mutations in ABL kinase domain are associated with inferior progression-free survival.
|
20367437 |
2010 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Mutations in ABL kinase domain are associated with inferior progression-free survival.
|
20367437 |
2010 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia.
|
18828913 |
2008 |
rs121913451
|
|
|
0.710 |
GeneticVariation |
BEFREE |
Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors.
|
18818391 |
2008 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Presence or the emergence of a F317L BCR-ABL mutation may be associated with resistance to dasatinib in Philadelphia chromosome-positive leukemia.
|
17114651 |
2006 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.
|
12623848 |
2003 |
rs121913451
|
|
A |
0.710 |
GeneticVariation |
CLINVAR |
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis.
|
12623848 |
2003 |
rs121913451
|
|
G |
0.710 |
GeneticVariation |
CLINVAR |
High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.
|
11964322 |
2002 |